| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
24-dehydrocholesterol reductase | 0.498 | 0.769 | 3.1E-02 |
|
disease | 0.400 | None | 0.958 | 3 | 0 | 2000 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2014 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.100 | None | 0.947 | 3 | 0 | 1998 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 1998 | 2003 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 0.502 | 0.808 | 2.2E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
8-oxoguanine DNA glycosylase | 0.453 | 0.808 | 3.9E-12 |
|
disease | 0.100 | None | 0.900 | 2 | 0 | 2002 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.985 | 1 | 0 | 1991 | 2020 | ||||||||
|
activating transcription factor 2 | 0.551 | 0.808 | 0.99 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2004 | 2005 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2009 | 2015 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.986 | 2 | 0 | 2000 | 2019 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
adhesion molecule with Ig like domain 2 | 0.729 | 0.615 | 0.60 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2004 | 2017 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2008 | 2017 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.978 | 4 | 0 | 1999 | 2019 | ||||||||
|
age-related maculopathy susceptibility 2 | 0.670 | 0.308 | 5.2E-04 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2012 | ||||||||
|
agrin | 0.626 | 0.538 | 5.5E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2009 | ||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
disease | 0.100 | None | 0.867 | 1 | 0 | 2004 | 2020 | ||||||||
|
alpha 2-HS glycoprotein | 0.506 | 0.846 | 3.2E-10 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
alpha-2-macroglobulin | 0.529 | 0.769 | 4.5E-11 |
|
disease | 0.500 | None | 0.769 | 4 | 0 | 1998 | 2018 | ||||||||
|
amyloid beta precursor like protein 2 | 0.659 | 0.462 | 0.38 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 1994 | 2012 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.900 | None | 0.981 | 81 | 0 | 1987 | 2020 | ||||||||
|
amyloid beta precursor protein binding family A member 1 | 0.743 | 0.346 | 0.54 |
|
disease | 0.070 | None | 1.000 | 2 | 0 | 1998 | 2010 | ||||||||
|
amyloid beta precursor protein binding family A member 3 | 0.839 | 0.192 | 2.1E-12 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 1999 | 2008 |